Insider trade

Autolus Therapeutics (AUTL): Officer exercised options on 20K shares

Cintia Piccina, Officer at Autolus Therapeutics, reported an option exercise of 20K shares.

20K
Shares · @ $2.35
Traded
Sep 1, 2026
Filed
Sep 3, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jul 30, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations (and 1 more item)
  2. Aug 11, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors

What came next

  1. Sep 2, 2026InsiderOfficer sold ~$16K of AUTL shares in the open market
  2. Nov 10, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
  3. Nov 10, 20265% stakeBXLS V - Autobahn L.P. filed an activist stake (13D) of 7.6%
  4. Nov 16, 20265% stakeMAK Capital Fund LP reported a passive stake (13G) of 11.5%
  5. Nov 16, 20265% stakeArmistice Capital, LLC reported a passive stake (13G) of 5.2%
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Autolus Therapeutics

For Autolus Therapeutics, OQRO holds 1 insider filing (SEC Form 4 or Form 144) and 2 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its AUTL page.

Other recent filings by Cintia Piccina, U.S. CCO & Country Gen Manager

The full history of Cintia Piccina, U.S. CCO & Country Gen Manager is on the profile page.

How this filing works

Explore the data

Common questions

Which Autolus Therapeutics (AUTL) insider traded, and how much?

Cintia Piccina, Officer at Autolus Therapeutics, reported an option exercise of 20K shares. At $2.35.

When did it happen, and when was it made public?

Traded: Sep 1, 2026. Filed: Sep 3, 2026. That is 2 days between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Autolus Therapeutics recently?

For Autolus Therapeutics, OQRO holds 1 insider filing (SEC Form 4 or Form 144) and 2 fund holdings reports (13F) dated in the last 90 days. They are listed on the AUTL page.

Does this mean AUTL stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Autolus Therapeutics

Everything OQRO holds on this company is on its AUTL page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data